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Novel Schiff bases, Furan-2-carboxylic acid pyridin-4-ylmethyleneamide , and Thiophene-2-carboxylic acid 1H-indol-2-
ylmethyleneamide and their mononuclear Ni(II) and Cu(II) complexes have been synthesized and characterized by 
elemental analysis, molar conductance, UV-visible, FT-IR, 1H NMR and EPR spectroscopy. The complexes are non-
electrolytes as evidenced from the molar conductance vaules. The ligands and their complexes have been tested for their 
antimicrobial activity against one gram positive bacteria, Bacillus subtilis, gram negative bacteria, Escherichia coli and 
fungi Candida albicans. It is found that metal complexes exhibited more activity than the free ligand. 
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The coordination chemistry of transition metals and 
their derivatives has got much attention in recent years
1
 
because many of the biological processes which are 
fundamental to life are controlled by transition metals
2
. 
Many of these coordination compounds possess 



















activities and plant growth regulating activity
15
. 
Nitrogen, oxygen and sulphur donor ligands possess a 
range of biological applications like antitumor, 
antibacterial, antifungal, antimalarial and antiviral 
activities
16
 and they can bind the biomolecules at their 
active sites
17
. Due to the excellent donor properties of 
azo group, the complexes containing azo groups 
exhibits excellent antimicrobial activity
18
. The presence 
of azomethine linage (C=N) present in certain 
compounds is also a basic structural necessity for 
biological activity
19





 and anticancer activities
21,22
 
have been observed for complexes containing 
azomethine linkage. 
Hydrazones which belongs to Schiff base family has 
the functional group (>N-N=C<) in which the 
azomethine group is adjacent to another nitrogen 
atom
23,24
. The biological activities of hydrazones are 
due to the presence of lone pair electrons of 𝑠𝑝2 
hybridized orbitals of azomethine nitrogen
24-26
. 
Hydrazones which contain an azomethine proton 
(–NHN=CH–) is therapeutically important for new 
drug development
27
. The additional donor site, >C=O 
of aroyl, acyl and heteroaroyl hydrazone Schiff base 
compounds makes the hydrazones more flexible and 
versatile. This additional donor site makes hydrazones 
as good polydentate chelating ligand and can 
coordinate with various transition and inner transition 
metals in numerous ways
23
. Hydrazones and their metal 
complexes show varied applications in the fields such 
as antifungal, antibacterial, antioxidative and cytotoxic 
studies
28
. They have been found to be potential 
chemotherapeutic agents. 
The characteristic properties of coordination 
compounds depends on the nature of donor atom, steric 
factors, nature of the metal ion, structure of the 
coordinating ligand, the metal-ligand interaction and 
the nature of the solvent employed
29
. Schiff bases show 
excellent biological activities against many pathogenic 
bacteria, fungi and against certain cancerous cells
18,30
. 
Schiff bases having chelative donor sites like nitrogen, 
oxygen and sulphur when coordinated to metal ions an 
enhanced biological activity is observed
7,31
.  
Generally metal chelates have enhanced activity 
than the free ligand
32
. As chelation increases biological 
activity also increases
7,31
 because chelation increases 
the cell permeability. On chelation the polarity of the 




This enhanced lipophilic nature favours cell 
permeability. Thus metal atoms can permeate more 
effectively through the lipid layer of microbes 
destroying th
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2.2H2O: Yield, 70 %; Colour: brown; 
Anal.(%), Expt. (Calc.): C,41.89 (42.09); H, 2.96 
(3.02); N, 6.89 (7.01); S, 7.92 (8.02); Absorption: 
(λmax, nm, acetonitrile): 243, 466; IR: (KBr, cm
-1
): 
1602 [ν(C=O)], 1576 [ν(C=N)], 1521 [ν(C=C)], 457 
[ν(Cu-CSC)], 3357 [ν(H2O)]; Molar conductivity, 
16.5 (DMF), 14.6 (acetonitrile) 
NiCl2L
2
2: Yield, 72 %; Colour: pale green; 
Anal.(%), Expt. (Calc.): C, 53.79 (53.89); H, 2.87 
(2.90); N, 8.95 (8.97); S, 10.24 (10.27); Absorption: 
(λmax, nm, acetonitrile): 242, 292; IR: (KBr, cm
-1
): 
1612 [ν(C=O)], 1576 [ν(C=N)], 1521[ν(C=C)], 3167 
[ν(N-H)], 460 [ν(Ni-CSC)], 530 [ν(Ni-O)]; Molar 
conductivity, 17. 1 (DMF), 15.4 (acetonitrile)  
 
Results and Discussion 





 were synthesized. and characterised by differrent 
characterization techniques like elemental analysis, 
molar conductivity measurements, 
1
H NMR, UV-visible 
absorption, and FT-IR. All the ligands and complexes 
were stable in room temperature and soluble in 
acetonitrile, DMF and DMSO. Molar conductivities of 
the complexes were recorded in 10
-3
 M solutions of 
DMF and acetonitrile. The molar conductivity values are 






) which indicate 
the non-electrolytic nature of complexes. 
 
1H NMR spectra of ligands 
The proton NMR spectra of the ligands are shown in 
Supplementary Data, Fig. S1. L
1
 displayed a singlet at 
δ, 12.1 ppm which is assigned to azomethine proton. 
The peaks due to protons on furan and pyridine rings 
are in the range δ, 6.7 to 8.6 ppm. L
2
 displayed a 
singlet at δ 9.9 ppm which is attributed to the indole 
NH and signal at δ, 12.1 ppm is ascribed to the 
azomethine proton. The resonance due to protons on 
thiophene and benzene rings are in the range δ, 7.1 to 
8.2 ppm (Supplementary Data, Table S1). 
 
IR spectra 
The IR spectra of the ligands and complexes showed 
various significant bands in the region of 4000-400 cm
-1
 
(Fig. 1), and their assignments were tentatively used to 
establish the mode of coordination as given in 
Supplementary Data, Table S2. A strong sharp band 
observed at 1244 cm
-1 
corresponds to the C-O group of 
L
1
 (Fig. 1a) which is lowered to 1231 cm
-1
 in the copper 





 lowered to 1618 cm
-1
 in complexes. Coordination of 
L
1 
to the Cu was further confirmed by the appearance of 
bands at 536 cm
-1
 corresponding to Cu–O bond. A 
strong sharp band at 1244 cm
-1
 corresponding to the C-O 
group of L
1
 is lowered to 1220 cm
-1
 in complexes nickel 





C=O was lowered to 1618 cm
-1
 in the Ni complexes. 
Coordination of L
1 
to the metal was further confirmed by 
the appearance of bands at 536 cm
-1
 Ni–O. A sharp band 
observed at 3381 cm
-1
 in nickel complex of L
1
 shows the 




Fig. 1 — IR spectra of (a) ligand L1, (b) Cu(II)- L1 and (c) Ni(II)- L1 complexes 




Fig. 2 shows the IR spectra of ligand L
2
 and its 
Cu(II) and Ni(II) complexes. As shown in Fig. 2b, a 
strong sharp band observed at 1602 cm
-1
 for copper 
complexes of L
2
 corresponds to the C=O group of the 
ligand coordinated to Cu. N-H stretching frequency in 
ligand and complexes remain unchanged in L
2
 
complexes. Coordination of ligand L
2
 to the metal was 
further confirmed by the appearance of band at  
536 cm
-1
 corresponding to Cu–O. A sharp band 
observed at 3357 cm
-1
 shows the presence of lattice 
water for copper complex of L
2
. A strong sharp band 
observed at 1612 cm
-1
 for nickel complexes of L
2
 
indicates that C=O group of the Ligand (Fig. 2c). N-H 
stretching frequency in ligand and complexes remain 
unchanged in L
2
 complexes. Coordination of ligand L
2
 
to the metal was further confirmed by the appearance 
of bands at 530 cm
-1
 corresponding to Ni–O.  
 
Electronic absorption spectra  
The electronic spectra of the ligands were recorded 
in the range of 200-900 nm region in acetonitrile 
solution (10
-5
 M) and are shown in Fig. 3. In absorption 
spectrum of the ligand L
1
 (Fig. 3a) band at 303 nm is 
assigned to π- π* transition and displayed bands for L
2
 
(Supplementary Data, Fig. S2a) at 249 and 273 nm are 
assigned to n-π* and π- π* transitions, respectively. For 
Cu(II) complex of L
1
, bands at 223, 293 and 458 nm 
are assigned to n- π*, π- π* and d-d transitions, 
respectively (Fig. 3b) and copper complex of L
2
 shows 
bands at 243 and 466, which are assigned to π- π* and 
d-d transitions, respectively (Fig. 3c). In the spectrum 
of Ni(II) complex of L
1
, bands at 223 and 290 nm are 
assigned to n- π* and π- π* transitions, respectively, 
and for nickel complex of L
2 
bands at 242 and 292 nm 
are assigned to n- π* and π- π* transitions, respectively 
(Supplementary Data, Fig. S2b). 
 
EPR spectral studies of copper complexes 
EPR spectrum of copper complexes of L
1
 was 
recorded in RT (300 K) as well as LNT (77 K) on X-
band at 9.1 GHz frequency and the magnetic field of 
3400 G in DMSO as solvent using DPPH as internal 
reference. In the complexes copper ion has oxidation 
state II and hence has d
1
 electronic configuration. The 
spectrum at RT shows one intense band at high field 
region (Fig. 4). The EPR spectrum of the powder at 
 
 




Fig. 3 — Absorption spectra of (a) ligand L1, (b) Cu(II)- L1 complex and (c) Ni(II)- L1 complex 




RT gave a giso= 2.10 (Aiso= 320). At LNT, the g∥ and 
g⊥(avg) are found to be 2.25 and 2.07 (A⊥=315), 
respectively. g∥>g⊥> 2.0023 indicate that the unpaired 




 of the Cu(II) ion. It is a 
characteristic of the axial symmetry with possibly a 






The antibacterial activity of ligand, L
2
 and its 
complexes with Ni(II) and Cu(II), were tested against 
the one gram positive bacteria, Bacillus subtilis and 
against one Gram negative bacteria Escherichia coli. 
The antifungal activity of the ligands and its complexes 
with Ni(II) and Cu(II) were tested against fungi, 
Candida albicans. The standard used for antibacterial 
study was ampicillin and that for antifungal studies was 
flucanazole. DMSO was used as solvent control. The 
values of zone inhibition were measured in millimeter. 
The zone of inhibition against standards and test 
samples are summarized in Table 1. The data reveal 
that the complexes have higher antimicrobial activities 
than the free ligand and it may be attributed to its 
higher stability constant
34
. Among the test complexes 
copper complexes exhibited greater microbial 
inhibition than the nickel complexes. 
 
Conclusions 
The present work has focused on the synthesis, 
characterization and antimicrobial studies of two new 
ligands and their Cu(II) and Ni(II) complexes derived 
from furan-2-carboxylic acid pyridin-4-
ylmethyleneamide (L
1
) and thiophene-2-carboxylic acid 
1H-indol-2-ylmethyleneamide (L
2
). The ligands and 
complexes were characterized by CHNS analysis, 
1
H 
NMR, UV-visible absorption, and FT-IR and EPR 
techniques. Molar conductivity measurements of the 
Cu(II) and Ni(II) complexes revealed their non-
electrolytic nature in acetonitrile and DMF. 
1
H NMR 
studies of the ligands correspond to the structure of the 
compound. FT-IR data showed the presence of lattice 




, and for nickel 
complex of L
1
. Lattice water is absent for nickel 
complex of L
2
. FT-IR data confirmed the coordination 
of ligand to the metal ion. Absorption spectra of 
complexes were studied for their n-π* and π-π* 
transitions. EPR studies suggest the possibility of square 
planar geometry or distorted octahedral geometry. The 
antimicrobial study of the ligand L
2
 and its Cu(II) and 
 
 
Fig. 4 — EPR spectrum of powder Cu(II)- L1 at room temperature 
 
 
Table 1 — Inhibitory activity of compounds and test organisms 
Test compound Conc. (µg/25 µL) Zone of inhibition (mm) 
Test organism 
Escherichia coli MTCC 7410 Bacillus subtilis MTCC 121 Candida albicans MTCC 183 
L1 10  - - 
 25 - - - 
L2 10 - - - 
 25 4.50 ±0.50 - 2.00 ±0.00 
CuCl2L
1
2. 2H2O 10 10.00 ± 0.0 16.00 ± 0.0 4.00 ± 0.00 
 25 12.00 ± 0.0 18.00 ± 0.0 6.00 ± 0.00 
CuCl2L
2
2. 2H2O 10 13.00 ± 0.0 13.00 ± 0.0 4.00 ± 0.00 
 25 15.00 ± 0.0 15.00 ± 0.0 7.50 ± 0.00 
NiCl2L
1
2. 2H2O 10 6.00 ± 0.0 - 2.00 ± 0.00 
 25 8.00 ± 0.0 - 2.00 ± 0.00 
NiCl2L
1
2. 2H2O 10 6.00 ± 0.0 - 2.00 ± 0.00 
 25 9.00 ± 0.0 - 2.00 ± 0.00 
Standard Ampicillinref 25 30.00 ± 0.5 35.00 ± 0.00 - 
Standard Fluconazoleref - - - 7.50 ± 0.00 




Ni(II) complexes showed microbial inhibition against 
the selected test microorganisms of bacteria and fungi. 
Among the test compounds copper complexes showed 
higher microbial inhibition activity. 
 
Supplementary Data 
Supplementary Data associated with this article  
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